Large-scale testing (Phase 3)Study completedNCT07712731What this trial is testingHPP737 in Adult Patients With Plaque PsoriasisWho this might be right forPsoriasis Newsoara Biopharma Co., Ltd. 607
Testing effectiveness (Phase 2)Study completedNCT04173637What this trial is testingClinical Study of AK101 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Akeso 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06926582What this trial is testingEvaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque PsoriasisWho this might be right forPsoriasis Hansoh BioMedical R&D Company 305
Testing effectiveness (Phase 2)UnknownNCT06058546What this trial is testingEfficacy and Safety of Jiuweihuaban Pill for Treating Plaque PsoriasisWho this might be right forPlaque Psoriasis Tasly Pharmaceutical Group Co., Ltd 180
Large-scale testing (Phase 3)Study completedNCT01365455What this trial is testingEfficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 YearWho this might be right forModerate to Severe Plaque-type Psoriasis Novartis Pharmaceuticals 738
Large-scale testing (Phase 3)Study completedNCT06973291What this trial is testingA Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisWho this might be right forPlaque Psoriasis Takeda 606
Testing effectiveness (Phase 2)Study completedNCT02129777What this trial is testingEfficacy and Safety of Namilumab (MT203) for Plaque PsoriasisWho this might be right forPlaque Psoriasis Takeda 122
Early research (Phase 1)Study completedNCT01484587What this trial is testingThe Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT03058744What this trial is testingTopically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 94
Post-approval studies (Phase 4)Looking for participantsNCT03987763What this trial is testingA Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 45
Large-scale testing (Phase 3)Looking for participantsNCT07511647What this trial is testingClinical Study of QL2106 InjectionWho this might be right forPlaque Psoriasis Qilu Pharmaceutical Co., Ltd. 318
Post-approval studies (Phase 4)Study completedNCT03331835What this trial is testingA Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Vulgaris LEO Pharma 210
Post-approval studies (Phase 4)Study completedNCT00581555What this trial is testingEvaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin TherapyWho this might be right forPsoriasis Pfizer 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06143878What this trial is testingJNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Janssen Research & Development, LLC 774
Post-approval studies (Phase 4)Study completedNCT02752776What this trial is testingEvaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.Who this might be right forPlaque Psoriasis Novartis Pharmaceuticals 1,660
Not applicableWithdrawnNCT03507946What this trial is testingSafety and Effectiveness of Combined LED Light for the Treatment of Mild to Moderate Plaque Type Psoriasis VulgarisWho this might be right forPsoriasis Vulgaris Ismart
Early research (Phase 1)UnknownNCT03424629What this trial is testingSafety and Efficacy of UC-MSCs in Patients With Plaque PsoriasisWho this might be right forModerate and Severe Plaque Psoriasis Tianjin Ever Union Biotechnology Co., Ltd. 57
Testing effectiveness (Phase 2)Looking for participantsNCT07449702What this trial is testingAn Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisWho this might be right forPlaque Psoriasis Oruka Therapeutics, Inc. 240
Post-approval studies (Phase 4)Study completedNCT03848871What this trial is testingThe Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis PatientsWho this might be right forPlaque Psoriasis Derm Research, PLLC 20
Testing effectiveness (Phase 2)Study completedNCT01098721What this trial is testingA Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeksWho this might be right forPsoriasis Welichem Biotech Inc. 61